Increased expression of EphA7 correlates with adverse outcome in primary and recurrent glioblastoma multiforme patients

BMC Cancer

Volumn 8, Issue , 2008, Pages

  Wang, Lin Fang ^a,b   Fokas, Emmanouil ^a   Juricko, Janko ^a   You, An ^a   Rose, Frank ^a   Pagenstecher, Axel ^a   Engenhart Cabillic, Rita ^a   An, Han Xiang ^a  

^a PHILIPPS UNIVERSITY MARBURG   (Germany)

^b HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

EPHRIN RECEPTOR A7; NIMUSTINE; TENIPOSIDE; VON WILLEBRAND FACTOR;

ADULT; AGED; ARTICLE; CANCER PATIENT; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE FREE SURVIVAL; FEMALE; FOLLOW UP; GENE OVEREXPRESSION; GLIOBLASTOMA; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; OVERALL SURVIVAL; PREDICTION; PROGNOSIS; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; RECURRENT CANCER; TUMOR RECURRENCE; TUMOR VASCULARIZATION; BIOSYNTHESIS; BRAIN TUMOR; CYTOLOGY; ENDOTHELIUM CELL; GENE EXPRESSION REGULATION; METABOLISM; MIDDLE AGED; PATHOLOGY; RECURRENT DISEASE; TREATMENT OUTCOME;

ADULT; AGED; BRAIN NEOPLASMS; ENDOTHELIAL CELLS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GLIOBLASTOMA; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; RECEPTOR, EPHA7; RECURRENCE; TREATMENT OUTCOME; VON WILLEBRAND FACTOR;

EID: 42249088607     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-8-79     Document Type: Article

References (60)

1. Ohgaki H Kleihues P Population-based studies on incidence, survival rates, and genetic alterations in astrocytic and oligodendroglial gliomas J Neuropathol Exp Neurol 2005, 64:479-489. 15977639
2. Reifenberger G Collins VP Pathology and molecular genetics of astrocytic gliomas J Mol Med 2004, 82:656-670. 10.1007/s00109-004-0564-x 15316624
3. Zhu Y Parada LF The molecular and genetic basis of neurological tumours Nat Rev Cancer 2002, 2:616-626. 10.1038/nrc866 12154354
4. Schlessinger J Ullrich A Growth factor signaling by receptor tyrosine kinases Neuron 1992, 9:383-391. 10.1016/0896-6273(92)90177-F 1326293
5. van der Geer P Hunter T Lindberg RA Receptor protein-kinases and their signal transduction pathways Annu Rev Cell Biol 1994, 10:251-337. 10.1146/annurev.cb.10.110194.001343 7888178
6. Flanagan JG Vanderhaeghen P The ephrins and Eph receptors in neural development Annu Rev Neurosci 1998, 21:309-345. 10.1146/ annurev.neuro.21.1.309 9530499
7. Holder N Klein R Eph receptors and ephrins: Effectors of morphogenesis Development 1999, 126:2033-2044. 10207129
8. Kullander K Klein R Mechanisms and functions of Eph and ephrin signaling Nat Rev Mol Cell Biol 2002, 3:475-486. 10.1038/nrm856 12094214
9. Pasquale EB Eph receptor signalling casts a wide net on cell behaviour Nat Rev Mol Cell Biol 2005, 6:462-475. 10.1038/nrm1662 15928710
10. Tessier-Lavigne M Eph receptor tyrosine kinases, axon repulsion, and the development of topographic maps Cell 1995, 82:345-348. 10.1016/ 0092-8674(95)90421-2 7634322
11. Winslow JW Moran P Valverde J Shih A Yuan JQ Wong SC Tsai SP Goddard A Henzel WJ Hefti F Beck KD Caras IW Cloning of AL-1, a ligand for an Eph-related tyrosine kinase receptor involved in axon bundle formation Neuron 1995, 14:973-981. 10.1016/0896-6273(95)90335-6 7748564
12. Wang HU Anderson DJ Eph family transmembrane ligands can mediate repulsive guidance of trunk neural migration and motor axon outgrowth Neuron 1997, 18:383-396. 10.1016/S0896-6273(00)81240-4 9115733
13. Martinez A Soriano E Functions of ephrin/Eph interactions in the development of the nervous system: Emphasis on the hippocampal system Brain Res Brain Res Rev 2005, 49:211-226. 10.1016/ j.brainresrev.2005.02.001 16111551
14. Lemke G A coherent nomenclature for Eph receptors and their ligands Mol Cell Neurosci 1997, 9:331-332. 10.1006/mcne.1997.0630 9361271
15. Holland SJ Gale NW Mbamalu G Yancopoulos GD Henkemeyer M Pawson T Bidirectional signaling through the EPH-family receptor Nuk and its transmembrane ligands Nature 1996, 383:722-725. 10.1038/383722a0 8878483
16. Davis S Gale NW Aldrich TH Maisonpierre PC Lhotak V Pawson T Goldfarb M Yancopoulos GD Ligands for EPH-related receptor tyrosine kinases that require membrane attachment or clustering for activity Science 1994, 266:816-819. 10.1126/science.7973638 7973638
17. Bundesen LQ Scheel TA Bregman BS Kromer LF Ephrin-B2 and EphB2 regulation of astrocyte-meningeal fibroblast interactions in response to spinal cord lesions in adult rats J Neurosci 2003, 23:7789-7800. 12944508
18. Nakada M Niska JA Tran NL McDonough WS Berens ME EphB2/R-Ras signaling regulates glioma cell adhesion, growth, and invasion Am J Pathol 2005, 167:565-576. 1603577 16049340
19. Nakada M Niska JA Miyamori H McDonough WS Wu J Sato H Berens ME The Phosphorylation of EphB2 Receptor Regulates Migration and Invasion of Human Glioma Cells Cancer Res 2004, 64:3179-3185. 10.1158/ 0008-5472.CAN-03-3667 15126357
20. Erber R Eichelsbacher U Powajbo V Korn T Djonov V Lin J Hammes HP Grobholz R Ullrich A Vajkoczy P EphB4 controls blood vascular morphogenesis during postnatal angiogenesis EMBO J 2006, 25:628-641. 1383533 16424904 10.1038/sj.emboj.7600949
21. Nakada M Drake KL Nakada S Niska JA Berens ME Ephrin-B3 Ligand Promotes Glioma Invasion through Activation of Rac1 Cancer Res 2006, 66:8492-8500. 10.1158/0008-5472.CAN-05-4211 16951161
22. Hatano M Eguchi J Tatsumi T Kuwashima N Dusak JE Kinch MS Pollack IF Hamilton RL Storkus WJ Okada H EphA2 as a glioma-associated antigen: A novel target for glioma vaccines Neoplasia 2005, 7:717-722. 1501889 16207473 10.1593/neo.05277
23. Liu FH Park PJ Lai W Maher E Chakravarti A Durso L Jiang X Yu Y Brosius A Thomas M Chin L Brennan C DePinho RA Kohane I Carroll RS Black PM Johnson MD A genome-wide screen reveals functional gene clusters in the cancer genome and identifies EphA2 as a mitogen in glioblastoma Cancer Res 2006, 66:10815-10823. 10.1158/0008-5472.CAN-06-1408 17090523
24. Taneja R Thisse B Rijli FM Thisse C Bouillet P Chambon P The expression patter of the mouse receptor tyrosine kinase gene MDK1 is conserved through evolution and requires Hoxa-2 for rhombomere-specific expression in mouse embryos Dev Biol 1996, 177:397-412. 10.1006/dbio.1996.0173 8806819
25. Ciossek T Millauer B Ulrich A Identification of alternatively spliced mRNAs encoding variants of MDKs, a novel receptor tyrosine kinase expressed in the murine nervous system Oncogene 1995, 10:97-108. 7824284
26. Valenzuela DM Rojas E Griffiths JA Compton DL Gisser M Ip NY Goldfarb M Yancopoulos GD Identification of full length and truncated forms and Ehk-3, a novel member of the Eph receptor tyrosine kinase family Oncogene 1995, 10:1573-1580. 7731712
27. Ciossek T Ullrich A West E Rogers JH Segregation of the receptor EphA7 form its tyrosine kinase-negative isoform on neurons in adult mouse brain Molecular Brain Res 1999, 74:231-236. 10.1016/S0169-328X(99)00285-5
28. Rogers JH Ciossek T Ullrich A West E Hoare M Muir EM Distribution of the receptor EphA7 and its ligands in development of the mouse nervous system Molecular Brain Res 1999, 74(1-2):225-230. 10.1016/ S0169-328X(99)00284-3 10640695
29. Holmberg J Clarke DL Frisén J Regulation of repulsion versus adhesion by different splice forms of an Eph receptor Nature 2000, 408:203-206. 10.1038/35041577 11089974
30. Figueroa JD Benton RL Velazquez I Torrado AI Ortiz CM Hernandez CM Diaz JJ Magnuson DS Whittemore SR Miranda JD Inhibition of EphA7 up-regulation after spinal cord injury reduces apoptosis and promotes locomotor recovery J Neuroscience Res 2006, 84(7):1438-1451. 10.1002/ jnr.21048 16983667
31. Depaepe V Suarez-Gonzalez N Dufour A Passante L Gorski JA Jones KR Ledent C Vanderhaeghen P Ephrin signaling controls brain size by regulation apoptosis of neural progenitors Nature 2005, 435:1244-1250. 10.1038/nature03651 15902206
32. Weidner N Semple JP Welch WR Folkman J Tumor angiogenesis and metastasis-correlation in invasive breast carcinoma N Engl J Med 1991, 324:1-8. 1701519
33. Wykosky J Gibo DM Stanton C Debinski W EphA2 as a novel molecular marker and target in glioblastoma multiforme Mol Cancer Res 2005, 3:541-551. 10.1158/1541-7786.MCR-05-0056 16254188
34. Walker-Daniels J Coffman K Azimi M Rhim JS Bostwick DG Snyder P Kerns BJ Waters DJ Kinch MS Overexpression of the EphA2 tyrosine kinase in prostate cancer Prostate 1999, 41:275-280. 10.1002/ (SICI)1097-0045(19991201)41:4<275::AID-PROS8>3.0.CO;2-T 10544301
35. Kinch MS Moore MB Harpole DH Jr Predictive Value of the EphA2 Receptor Tyrosine Kinase in lung cancer recurrence and survival Clin Cancer Res 2003, 9:613-618. 12576426
36. Miyazaki T Kato H Fukuchi M Nakajima M Kuwano H EphA2 overexpression correlates with poor prognosis in esophogeal squamous cell carcinoma Int J Cancer 2003, 103:657-663. 10.1002/ijc.10860 12494475
37. Easty DJ Hill SP Hsu MY Fallowfield ME Florenes VA Herlyn M Bennett DC Up-regulation of ephrin-A1 during melanoma progression Int J Cancer 1999, 84:494-501. 10.1002/ (SICI)1097-0215(19991022)84:5<494::AID-IJC8>3.0.CO;2-O 10502726
38. Thaker PH Deavers M Celestino J Thornton A Fletcher MS Landen CN Kinch MS Kiener PA Sood AK EphA2 expression is associated with aggressive features in ovarian carcinoma Clin Cancer Res 2004, 10:5145-5150. 10.1158/1078-0432.CCR-03-0589 15297418
39. Wu D Suo Z Kristensen GB Li S Troen G Holm R Nesland JM Prognostic value of EphA2 and EphrinA-1 in squamous cell cervical carcinoma Gynecol Oncol 2004, 94:312-319. 10.1016/j.ygyno.2004.05.019 15297167
40. Zelinski DP Zantek ND Stewart JC Irizarry AR Kinch MS EphA2 overexpression causes tumorigenesis of mammary epithelial cells Cancer Res 2001, 61:2301-2306. 11280802
41. Nakamura R Kataoka H Sato N Kanamori M Ihara M Igarashi H Ravshanov S Wang YJ Li ZY Shimamura T Kobayashi T Konno H Shinmura K Tanaka M Sugimura H EPHA2/EFNA1 expression in human gastric cancer Cancer Sci 2005, 96:42-47. 15649254
42. Kataoka H Igarashi H Kanamori M Ihara M Wang JD Wang YJ Li ZY Shimamura T Kobayashi T Maruyama K Nakamura T Arai H Kajimura M Hanai H Tanaka M Suqimura H Correlation of EphA2 overexpression with high microvessel count in human primary colorectal cancer Cancer Sci 2004, 95:136-141. 10.1111/j.1349-7006.2004.tb03194.x 14965363
43. Hafner C Schmitz G Meyer S Bataille F Hau P Langmann T Dietmaier W Landthaler M Vogt T Differential gene expression of Eph receptors and ephrins in benign human tissues and cancers Clin Chem 2004, 50:490-499. 10.1373/clinchem.2003.026849 14726470
44. Surawska H Ma PC Salgia R The role of ephrins and Eph receptors in cancer Cytokine Growth Factor Rev 2004, 15:419-433. 10.1016/ j.cytogfr.2004.09.002 15561600
45. Nakanishi H Nakamura T Canaani E Croce CM ALL1 fusion proteins induce deregulation of EphA7 and ERK phosphorylation in human acute leukemias Proc Natl Acad Sci USA 2007, 104:14442-14447. 1964835 17726105 10.1073/ pnas.0703211104
46. Wang JD Kataoka H Suzuki M Sato N Nakamura R Tao H Maruyama K Isogaki J Kanaoka S Ihara M Tanaka M Kanamori M Nakamura T Shinmura K Sugimura H Downregulation of EphA7 by hypermethylation in colorectal cancer Oncogene 2005, 24:5637-5647. 10.1038/sj.onc.1208720 16007213
47. Mitelman F Johansson B Mertens F Mitelman Database of Chromosome Aberrations in Cancer http://cgap.nci.nih.gov/Chromosomes/Mitelman
48. Noren NK Foos G Hauser CA Pasquale EB The EphB4 receptor suppresses breast cancer cell tumorigenicity through an Abl-Crk pathway Nat Cell Biol 2006, 8:815-825. 10.1038/ncb1438 16862147
49. Xia G Kumar SR Masood R Koss M Templeman C Quinn D Zhu S Reddy R Krasnoperov V Gill PS Up-regulation of EphB4 in mesothelioma and its biological significance Clin Cancer Res 2005, 11:4305-4315. 10.1158/ 1078-0432.CCR-04-2109 15958611
50. Davis S Gale NW Aldrich TH Maisonpierre PC Lhotak V Pawson T Goldfarb M Yancopoulos GD Ligands for EPH-related receptors that require membrane attachment or clustering for activity Science 1994, 266:816-819. 10.1126/ science.7973638 7973638
51. Dawson DW Hong JS Shen RR French SW Troke JJ Wu YZ Chen SS Gui D Regelson M Marahrens Y Morse HC III Said J Plass C Teitell MA Global DNA methylation profiling reveals silencing of a secreted form of EphA7 in mouse and human germinal center B-cell lymphomas Oncogene 2007, 26:4243-4252. 10.1038/sj.onc.1210211 17260020
52. Brantley DM Cheng N Thompson EJ Lin Q Brekken RA Thorpe PE Muraoka RS Cerretti DP Pozzi A Jackson D Lin C Chen J Soluble Eph A receptors inhibit tumor angiogenesis and progression in vivo Oncogene 2002, 21:7011-7026. 10.1038/sj.onc.1205679 12370823
53. Gale NW Yancopoulos G Growth factors acting via endothelial cell specific receptor tyrosine kinases: VEGFs, angiopoietins, and ephrins in vascular development Genes 1999, 13(9):1055-1066. 10.1101/gad.13.9.1055
54. Yancopoulos GD Davis S Gale NW Rudge JS Wiegand SJ Holash J Vascular-specific growth factors and blood vessel formation Nature 2000, 407:242-248. 10.1038/35025215 11001067
55. Ogawa K Pasqualini R Lindberg RA Kain R Freeman Al Pasquale EB The ephrin-A1 ligand and its receptor, EphA2, are expressed during tumor neovascularization Oncogene 2000, 19:6043-6052. 10.1038/sj.onc.1204004 11146556
56. Mitra AP Datar RH Cote RJ Molecular Pathways in Invasive Bladder Cancer: New Insights Into Mechanisms, Progression, and Target Identification J Clin Oncol 2006, 24:5552-5564. 10.1200/JCO.2006.08.2073 17158541
57. Chantrain CF DeClerck YA Groshen S McNamara G Computerized quantification of tissue vascularization using high-resolution slide scanning of whole tumor sections J Histochem Cytochem 2003, 51:151-158. 12533523
58. Uzzan B Nicolas P Cucherat M Perret GY Microvessel density as a prognostic factor in women with breast cancer: A systematic review of the literature and meta-analysis Cancer Res 2004, 64:2941-2955. 10.1158/ 0008-5472.CAN-03-1957 15126324
59. Preusser M Heinzl H Gelpi E Schonegger K Haberler C Birner P Marosi C Hegi M Gorlia T Hainfellner JA European Organization for Research and Treatment of Cancer Brain Tumor Group Histopathologic assessment of hot-spot microvessel density and vascular patterns in glioblastoma: Poor observer agreement limits clinical utility as prognostic factors: A translational research project of the European Organization for Research and Treatment of Cancer Brain Tumor Group Cancer 2006, 107:162-170. 10.1002/cncr.21973 16721804
60. Korkolopoulou P Patsouris E Kavantzas N Konstantinidou AE Christodoulou P Thomas-Tsagli E Pananikolaou A Eftychiadis C Pavlopoulos PM Angelidakis D Rologis D Davaris P Prognostic implications of microvessel morphometry in diffuse astrocytic neoplasms Neuropathol Appl Neurobiol 2002, 28:57-66. 10.1046/j.1365-2990.2002.00367.x 11849564